499 related articles for article (PubMed ID: 32512891)
1. Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer.
Muñoz-Galván S; Carnero A
Cells; 2020 Jun; 9(6):. PubMed ID: 32512891
[TBL] [Abstract][Full Text] [Related]
2. Adipose-derived stem cells in ovarian cancer progression, metastasis, and chemoresistance.
Zhang W; Torres-Rojas C; Yue J; Zhu BM
Exp Biol Med (Maywood); 2021 Aug; 246(16):1810-1815. PubMed ID: 34229470
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets.
Ahmed N; Abubaker K; Findlay JK
Mol Aspects Med; 2014 Oct; 39():110-25. PubMed ID: 23811037
[TBL] [Abstract][Full Text] [Related]
4. Regulation of ovarian cancer stem cells or tumor-initiating cells.
Kwon MJ; Shin YK
Int J Mol Sci; 2013 Mar; 14(4):6624-48. PubMed ID: 23528891
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance.
Mihanfar A; Aghazadeh Attari J; Mohebbi I; Majidinia M; Kaviani M; Yousefi M; Yousefi B
J Cell Physiol; 2019 Apr; 234(4):3238-3253. PubMed ID: 30317560
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer stem cells: What progress have we made?
Al-Alem LF; Pandya UM; Baker AT; Bellio C; Zarrella BD; Clark J; DiGloria CM; Rueda BR
Int J Biochem Cell Biol; 2019 Feb; 107():92-103. PubMed ID: 30572025
[TBL] [Abstract][Full Text] [Related]
7. [The role of cancer stem cells in progressive growth and resistance of ovarian cancer: true or fiction?].
Bar JK; Grelewski P; Lis-Nawara A; Drobnikowska K
Postepy Hig Med Dosw (Online); 2015 Sep; 69():1077-86. PubMed ID: 26400893
[TBL] [Abstract][Full Text] [Related]
8. New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools.
Muñoz-Galván S; Felipe-Abrio B; García-Carrasco M; Domínguez-Piñol J; Suarez-Martinez E; Verdugo-Sivianes EM; Espinosa-Sánchez A; Navas LE; Otero-Albiol D; Marin JJ; Jiménez-García MP; García-Heredia JM; Quiroga AG; Estevez-Garcia P; Carnero A
J Exp Clin Cancer Res; 2019 Jun; 38(1):234. PubMed ID: 31159852
[TBL] [Abstract][Full Text] [Related]
9. Ovarian Cancer-Insights into Platinum Resistance and Overcoming It.
Havasi A; Cainap SS; Havasi AT; Cainap C
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984544
[TBL] [Abstract][Full Text] [Related]
10. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
11. Eliminating ovarian cancer stem cells: a potential therapeutic target for ovarian cancer chemoresistance.
Wang X; Li X; Fu X; Bai M; Li X; Mei Q; Nie J; Wu Z; Han W
Curr Protein Pept Sci; 2015; 16(4):270-8. PubMed ID: 25929861
[TBL] [Abstract][Full Text] [Related]
12. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
13. Role of the microenvironment in ovarian cancer stem cell maintenance.
Pasquier J; Rafii A
Biomed Res Int; 2013; 2013():630782. PubMed ID: 23484135
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Foxo3 and TRIM31 by miR-551b in side population promotes cell proliferation, invasion, and drug resistance of ovarian cancer.
Wei Z; Liu Y; Wang Y; Zhang Y; Luo Q; Man X; Wei F; Yu X
Med Oncol; 2016 Nov; 33(11):126. PubMed ID: 27743201
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells.
Yang W; Kim D; Kim DK; Choi KU; Suh DS; Kim JH
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064635
[TBL] [Abstract][Full Text] [Related]
16. Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches.
Aguilar-Gallardo C; Rutledge EC; Martínez-Arroyo AM; Hidalgo JJ; Domingo S; Simón C
Stem Cell Rev Rep; 2012 Sep; 8(3):994-1010. PubMed ID: 22278130
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
Glackin CA
Enzymes; 2018; 44():83-101. PubMed ID: 30360816
[TBL] [Abstract][Full Text] [Related]
18. Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism.
Li SS; Ma J; Wong AST
J Gynecol Oncol; 2018 Mar; 29(2):e32. PubMed ID: 29468856
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer stem cells: elusive targets for chemotherapy.
Guddati AK
Med Oncol; 2012 Dec; 29(5):3400-8. PubMed ID: 22638913
[TBL] [Abstract][Full Text] [Related]
20. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
